Safety issues of Lactobacillus bulgaricus with respect to human gelatinases in vitro.
In oral medicine and dentistry probiotics have shown promising results in controlling dental diseases and yeast infections. This study was made to investigate the effect of eight strains of Lactobacillus bulgaricus and their effects on human matrix metalloproteinase-9 (MMP-9). The hypothesis was that these bacteria used in yoghurt production for centuries are not proteolytic and thus can be safely used in the development of probiotic preparations. Bacterial cell fractions and supernatant specimens were prepared and studied with gelatinase zymography and MMP-9 activation was assessed by immunoblotting. The effect of synthetic MMP inhibitors and a serine protease inhibitor (Pefabloc) on bacterial proteinases was studied with zymography. The results showed very low gelatinolytic activity. There was a slight difference between the supernatant and cell fractions so that the supernatant specimens produced weak gelatinolytic bands in zymography while hardly anything was seen in the cell fraction series. The tested synthetic MMP inhibitors and Pefabloc did not affect the proteolytic activity of the lactobacilli strains. The lactobacilli did not seem to induce the conversion of proMMP-9 to its active form. Consequently, our study hypothesis was confirmed and the studied Lactobacillus strains are not likely to degrade host tissue components.
Stamatova
Iva
I
Institute of Dentistry, University of Helsinki, Helsinki, Finland. iva.stamatova@avb.bg
Meurman
Jukka H
JH
Kari
Kirsti
K
Tervahartiala
Taina
T
Sorsa
Timo
T
Baltadjieva
Maria
M
D004792:Enzyme Precursors / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007778:Lactobacillus / Q000502:physiology*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D019936:Probiotics / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology; D012449:Safety
D004792:Enzyme Precursors; D011480:Protease Inhibitors; D020780:Matrix Metalloproteinase 9